Showing results (61-70 of 178) with videos related to

Sort By:
Pageof 18
Annals of the Rheumatic Diseases|November 26, 2009
Tumour necrosis factor {alpha} blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort studyMike J L Peters, Paul Welsh, Iain B McInnes, et al.
Rheumatology (Oxford, England)|February 17, 2023
Self-monitoring combined with patient-initiated care in RA patients with low disease activity: cost-effectiveness analysis of an RCTBart F Seppen, Marjolein J E Greuter, Jimmy Wiegel, et al.
British Journal of Clinical Pharmacology|August 10, 2017
Dried blood spots from finger prick facilitate therapeutic drug monitoring of adalimumab and anti-adalimumab in patients with inflammatory diseasesEva L Kneepkens, Mieke F Pouw, Gerrit Jan Wolbink, et al.
The Journal of Rheumatology|August 3, 2014
Adalimumab significantly reduces the recurrence rate of anterior uveitis in patients with ankylosing spondylitisJ Christiaan van Denderen, Ingrid M Visman, Michael T Nurmohamed, et al.
BMC Musculoskeletal Disorders|August 22, 2012
Cardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: a cross-sectional study in primary careMarkus M J Nielen, Alper M van Sijl, Mike J L Peters, et al.
Nature Reviews. Rheumatology|February 22, 2012
Validated methods for assessment of subclinical atherosclerosis in rheumatologyGyörgy Kerekes, Pál Soltész, Michael T Nurmohamed, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 12, 2022
Smartphone-Assisted Patient-Initiated Care Versus Usual Care in Patients With Rheumatoid Arthritis and Low Disease Activity: A Randomized Controlled TrialBart Seppen, Jimmy Wiegel, Marieke M Ter Wee, et al.
Plos One|August 4, 2020
Cardiovascular risk in persons at risk of developing rheumatoid arthritisLaurette van Boheemen, Marian H van Beers-Tas, Johanna M Kroese, et al.
Annals of the Rheumatic Diseases|August 14, 2014
Anti-adalimumab antibodies and adalimumab concentrations in psoriatic arthritis; an association with disease activity at 28 and 52 weeks of follow-upErik H Vogelzang, Eva L Kneepkens, Michael T Nurmohamed, et al.
BMJ Open|January 19, 2026
Impact of vitamin D non-reimbursement policy on therapy discontinuation in the general and rheumatic population in the Netherlands: a cross-sectional studyAmit Singh, Victor Huiskes, Bart van den Bemt, et al.
Pageof 18